Were on the cusp of providing human proof-of-idea data for our antibiotic.

Every year in the US, there are more than ten million patient appointments for treatment of pores and skin infections. Difficile disease, candidiasis or diarrhea, while providing high potency against the desired target , remarked Nachum Kaplan, Ph.D, Vice President of Microbiology in Affinium. .. Affinium initiates AFN-1252 Phase 2 trial in acute bacterial skin & skin framework infections Affinium Pharmaceuticals announced today dosing of the initial patient in a multi-center Phase 2 clinical trial evaluating oral AFN-1252 in acute bacterial skin & skin structure attacks . The Phase 2 research will confirm efficacy and tolerability of 200 mg of oral AFN-1252 dosed twice daily for 5-14 days in individuals with staphylococcal skin attacks.However, there were no significant differences between the two groups in reported genital discharge or dysuria. Male Acquisition and Circumcision of Syphilis To look for the efficacy of circumcision in preventing syphilis, subjects who all tested negative for T and HIV. Pallidum infections at baseline were evaluated for active T. Pallidum illness during follow-up. Enrollment characteristics were similar in both study groups. At 24 months, syphilis was detected in 50 of 2083 subjects in the intervention group, as compared with 45 of 2143 subjects in the control group .